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Background: Staphylococcus aureus remains a leading cause of hospital-acquired infec-
tion but weaknesses inherent in currently available typing methods impede effective
infection prevention and control. The high resolution offered by whole genome sequencing
has the potential to revolutionise our understanding and management of S. aureus
infection.
Aim: To outline the practicalities of whole genome sequencing and discuss how it might
shape future infection control practice.
Methods: We review conventional typing methods and compare these with the potential
offered by whole genome sequencing.
Findings: In contrast with conventional methods, whole genome sequencing discriminates
down to single nucleotide differences and allows accurate characterisation of transmission
events and outbreaks and additionally provides information about the genetic basis of
phenotypic characteristics, including antibiotic susceptibility and virulence. However,
translating its potential into routine practice will depend on affordability, acceptable
turnaround times and on creating a reliable standardised bioinformatic infrastructure.
Conclusion: Whole genome sequencing has the potential to provide a universal test that
facilitates outbreak investigation, enables the detection of emerging strains and predicts
their clinical importance.
ª 2012 The Healthcare Infection Society. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license. Introduction
In the field of infection control, our understanding of
Staphylococcus aureus transmission is limited by the methods
used to determine the relatedness of micro-organisms in thent of Infectious Diseases
tal, Eastern Road, Brigh-
7516.
.R. Price).
ociety. Published by Elseviercontext of time and space. Conventional typing methods, such
as phage typing, multi-locus sequence typing (MLST) and
pulsed-field gel electrophoresis (PFGE), have been used
successfully to describe the global population structure of
S. aureus, to provide a framework for the description of the
major lineages associated with healthcare-associated infec-
tions in different countries and to monitor their emergence,
dispersal and decline in different settings. However, conven-
tional typing methods have serious limitations when used
to investigate the finer details of infection outbreaks.1Ltd. Open access under CC BY-NC-ND license. 
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to ‘rule out’ suspected transmission events in the absence of
additional epidemiological information, since representatives
of the same type are often found all around the world. For
example, when investigating a cluster of MRSA cases in
a healthcare setting where a particular MRSA strain has become
endemic, conventional methods would most likely fail to
distinguish between those unlinked cases that happen to
belong to the same lineage and other cases that are truly
connected via recent transmission. Conversely, when the
typing method depends on phenotypic characterization such as
antibiotic susceptibility profiles, isolates that are truly linked
via transmission events might not be recognized as such
because the characteristics they measure are encoded on
mobile genetic elements.2,3
Whole genome sequencing (WGS) allows clinical isolates of
S. aureus to be compared with each other and with reference
sequences across time and space, down to a resolution of
a single nucleotide difference.4 This enhances our knowledge
of the population structure of S. aureus, allowing greater
precision in describing and defining the different lineages,
provides insights into the evolutionary history of lineages and
offers the potential for an outbreak investigator to determine
unambiguously the relatedness of isolates. By comparing the
relatedness of two isolates with the resolution offered by
whole genome sequences, and using estimates of the genome’s
mutation rate, it is possible to estimate the time elapsed since
their descent from a common ancestor with precision.4
Combined with epidemiological data, such as information on
dates of admission to hospital, it is then possible to draw
inferences about the probability that a transmission event
occurred or not, with sufficient accuracy to direct better tar-
geting of infection control resources.5 In fact, refinements in
genealogical approaches to sequence data analysis offer the
prospect of being able to make such inferences even in the
absence of supporting epidemiological information (X. Didelot,
D. Eyre, M. Cule, et al., unpublished data).
These properties give WGS the potential to revolutionize
infection control practice on local, national and international
scales. Sequence data interpreted in the context of epidemio-
logical surveillance data will allow the rapid detection of new
emerging strains. At a local level awareness of patterns of
transmission and prompt outbreak recognition (as early as the
detection of the first secondary case) will permitmore effective
interventions to be instigated. At an individual patient level,
the genetic basis for phenotypic characteristics of relevance to
clinical case management, such as antibiotic susceptibility and
virulence factors, may also be determined using the same
method. However, there remain major hurdles to be overcome
to translate WGS from a research tool into clinical practice.
These include cost, turnaround time and bioinformatic analysis.
Current rates of progress suggest that most of these difficulties
should be overcome in the fairly near future.
Evolutionary history and population structure of
Staphylococcus aureus
Staphylococcus aureus is a human commensal that is carried
by approximately one-third of the general population.6 Sites
for colonization include the anterior nares, the throat, the
axilla, and the perineum.7 Different patterns of carriage have
been described: people may be persistent carriers (20%),intermittent carriers (30%), or non-carriers (50%).6 Prior
asymptomatic carriage is a significant risk factor for the
development of invasive disease (relative risk: 16.7; 95%
confidence interval: 8.6e32.5), and recent acquisition is
associated with an increased risk of poor medical outcome.8,9
Overall, hospital-acquired S. aureus bacteraemia is associ-
ated with a mortality rate of 24%.10 This capacity for superficial
carriage and aggressive infection underlies the importance of
S. aureus as a nosocomial pathogen.
The circular genome of S. aureus is composed of about 2.8
million nucleotides and is about one thousand times smaller
than the human genome (about three billion nucleotides).11
Most of the genome (the core genome) is composed of genes
present in all strains that encode proteins involved in funda-
mental functions such as cellular metabolism, growth and
replication. About 10% of the genome consists of sets of genes
that vary between different lineages and is designated the
‘core variable genome’.12 Between 10% and 20% of the genome
consists of ‘mobile genetic elements’; regions that are gained
and lost by organisms at high frequencies (lateral gene trans-
fer) and which often encode virulence factors and resistance
genes.
Staphylococcus aureus has a markedly clonal population
structure.13e16 Most disease-causing isolates belong to a small
number of lineages or clonal complexes. Indeed most of the
strains that colonize humans belong to one of ten dominant
lineages.12 Within this structure differences in the core genome
occur as a result of point mutation and to a lesser extent
through recombination events.13 The necessity to disentangle
the evolutionary signals caused by mutation and recombination
is a common issue in any sequence-based analysis of bacteria,
and statistical methods are being developed to deal with
this difficulty by explicitly accounting for the role of
recombination.17e19 The conserved genomic structure of the
successful lineages has been explained by the presence of
enzymic restriction modification systems that limit acquisition
of foreign DNA.20 In recent decades, two epidemic lineages,
designated EMRSA-15 and EMRSA-16 (originally defined by
phage typing patterns), became the dominant healthcare-
associated strains in the UK.What methods are currently used to type
S. aureus?
Phenotypic typing methods that exploit variations in
observable strain characteristics such as antibiotic suscepti-
bility pattern, phage typing profile, and serotype are relatively
inexpensive but poorly discriminatory.21,22 Among the most
widely usedmolecular typingmethods aremulti-locus sequence
typing (MLST), staphylococcal protein A (spa)-typing, pulsed-
field gel electrophoresis (PFGE) and multi-locus variable
number tandem repeat analysis (MLVA). MLST is based on
sequence variation in housekeeping genes.23,24 MLST classifies
S. aureus strains into groups that reflect phylogeny, allowing the
study of population structure and evolutionary history.13,25,26
Different MLST sequence types can be grouped into clonal
complexes (CC) on the basis that they share some of the seven
(or more) loci.27 By contrast, spa-typing is based on the highly
variable X-region of a single gene (spa) that encodes protein
A.28 Concordance between MLST and spa-typing is high so that
spa-typing is now used widely for MRSA typing.29 In PFGE,
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sizes which form strain-specific patterns when separated by gel
electrophoresis.30 Compared with MLST and spa-typing, PFGE is
relatively good at resolving differences between strains and
many authors have promoted it as a tool for local outbreak
investigation.31,32 MLVA uses multiplex polymerase chain
reaction (PCR) to amplify known genetic loci containing varying
length random repeats, which again are separated into strain-
specific patterns by electrophoresis.33 MLVA has been shown to
have powers of discrimination similar to those of PFGE, and
MLVA results are highly concordant with those generated by
MLST and spa-typing.33e37
The determinant of meticillin resistance in MRSA, the mecA
gene, is part of a mobile genetic element, the staphylococcal
cassette chromosome element (SCCmec).38 Hence, MRSA
strains may be classified and typed according to the composi-
tion of SCCmec.39,40 Matrix-assisted laser desorption/ion-
izationetime of flight (MALDI-TOF) allows rapid identification
of organisms through molecular mass profiling of protein
biomarkers.41 MALDI-TOF technology has recently been evalu-
ated as a typing tool and has been shown to allow categoriza-
tion of MRSA into lineages based on diversity of protein
profiles.42
Why sequence the whole genome to type
S. aureus?
The current diversity of methods for characterizing
S. aureus results in inconsistencies in nomenclature and
hinders communication. Table I shows the differences in cost,
practicalities and achievable resolutions of conventional typing
techniques and WGS. A unified typing scheme linked to a freely
accessible universal database would be ideal. WGS resolves
differences between isolates down to the level of individual
nucleotides. Because of poor resolution, conventional methods
generate inconclusive results. For example, when two isolates
are indistinguishable it does not mean that they are identical.
WGS makes it possible to determine when sequences really are
identical, and, if not, to state exactly by how much they differ.
This allows inferences to be made about the relationships
between strains not just in terms of global population structure
but also in terms of local patterns of transmission.Table I
Comparison of the Staphylococcus aureus typing techniques
Technique Set-up
cost
Cost per
isolate
Current availability Time to
results
PFGE Low £4e7 Local and reference
laboratories
2e3 days
MLVA Low £3e5 Research and reference
laboratories
24 h
MLST High £20 Research and reference
laboratories
Days
spa High £3e5 Local and reference
laboratories
24 h
WGS High w£100 Research laboratories Real timea
PFGE, pulsed-field gel electrophoresis; MLVA, multi-locus variable-numb
spa-typing; WGS, whole genome sequencing.
a Third generation sequencing platforms.Conventional typing methods fail to reveal the fine details of
the genetic differences that accumulate between strains as
S. aureus diversifies, as DNA polymerases make copying
mistakes, point mutations occur, recombination events take
place andmobile elements are gained and lost. Even when used
in combination, conventional methods are limited in their
potential to distinguish between isolates within a major
lineage. WGS offers a portable, reproducible method to detect
the smallest of genetic differences.
Whole genome sequencing of Staphylococcus
aureus: practicalities
Platforms
Whole genome sequencing refers to the construction of the
complete nucleotide sequence of a genome. In 1977, Sanger
et al. developed a method that revealed the first complete
genome sequence of a virus.43 This ‘first generation sequencing’
used capillaryeelectrophoresis methods to sequence DNA
fragments, a process that was expensive and slow.44 The terms
‘second generation’ or ‘next generation’ sequencing (NGS) refer
to methods that parallelize the sequencing process, thus
dramatically lowering costs and increasing capacity. NGS first
became available in 2004 and a number of different sequencing
platforms are currently commercially available.45 These include
the Illumina Platform (Illumina, San Diego, CA, USA), 454
genome sequencer (Roche Applied Science, Rotkreuz,
Switzerland), SOLiD platform (Life Technologies, Applied Bio-
systems, Carlsbad, CA, USA) as well as the first bench-top
machines such as the MiSeq (Illumina) and IonTorrent plat-
forms (Life Technologies) which are anticipated to be among the
first platforms to be routinely implemented for clinical appli-
cations. Late in 2012 it is anticipated that the GridION platform
(Oxford Nanopore, Oxford, UK) will enter the marketplace.46
Genome assembly
Sequencing machines generate thousands of small DNA
sequences, called reads, which can be between 40 and 1000
base pairs in length depending on the technique used. Each
read represents the sequence of a small fraction of theData
analysis
Data
transferability
Common
nomenclature
Level of
resolution
Minimal Limited USA type (USA-) Lineage
Minimal Limited MLVA complex (Sa-) Lineage
Moderate Yes e widely Sequence type (ST-) Lineage
Moderate Yes e widely Spa-type (t-) Lineage
High Being addressed To be determined Base pair
er tandem-repeat analysis; MLST, multi-locus sequence typing; spa,
Table II
Comparison of sequencing technologies
Sequencing technology platform
First
generation
Second
generation
Third
generation
Resolution Average
of multiple
DNA copies
Average
of multiple
DNA copies
Single molecule
Read length
generated
800e1000 bp <400 bp 1000e10,000 bp
Financial cost
per base
High Low Moderate
Financial cost
per run
Low High Low
Sample
preparation
Moderate Complex Variable
Time to result Hours Days Minutes to hours
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is included in several reads. This number is called ‘the
coverage’. To be useful, the reads need to be assembled into
the whole genome sequence. This can be done in one of two
ways; either by comparison with a previously sequenced
‘reference’ strain (mapping-based assembly), or by piecing the
reads together on the basis of their overlaps (de novo
assembly).47,48 Mapping-based assembly produces results that
are easier to interpret, but are dependent upon the choice of
reference genome, so that sequences not present in the
reference genome remain unmapped. In principle, de novo
assembly can recover the whole genome, but in practice it
returns several assembled regions (called contigs) whose
further assembly tends to remain unresolved. In either case,
longer read lengths and higher coverage make assembly easier
and more accurate.49 Storing the reads for a single S. aureus
genome requires about 1 GB of storage space; roughly equiv-
alent to 10 music albums in MP3 format. The term high-
throughput sequencing is used to refer to newer sequencing
technologies that can generate sequence data faster and more
economically than previous platforms. Consequently,
sequencing platforms are rated according to their throughput
speeds, set-up and processing costs and length of reads
produced.45 A medium-sized sequencing facility can process
thousands of bacterial isolates in a year. New platforms (Oxford
Nanopore and Ion Proton) offer the promise of projected cost
reductions to the order of US $1,000 for a whole human
genome, sequenced in 15 min to 2 h. Such performance would
translate into sequencing costs for bacteria of about US $1 per
whole genome.
Limitations
Current approaches to whole genome sequencing have
inherent limitations. At present, using high throughput
sequencing machines takes several weeks to generate a DNA
sequence due to complex sample preparation, large numbers
of scanning/washing cycles and reliance on PCR amplification
of DNA templates. Furthermore the reads produced are rela-
tively short which can make genome assembly challenging. At
the time of writing it is important to realize that the limitations
of mapping-based and de novo assembly techniques for short
read sequences mean that the term ‘whole genome sequence’
actually refers to the 80e90% of the entire genome that is
actually rendered visible by those techniques. The introduction
of new platforms that generate much longer reads will make
visible the remaining ‘concealed’ sequences to routine
analysis.
Third generation sequencing
A major recent milestone has been the development of
technology to allow sequencing of genomes to be performed in
real-time. This is termed ‘third generation sequencing’
(TGS).44 Instead of fragmenting and reconstructing read
sequences, TGS platforms allow direct observation of the DNA
polymerase enzyme while it constructs a strand of DNA. By not
having to pause between individual base identification, and by
taking advantage of the enzyme’s speed in adding nucleotide
bases to the growing chain, the throughput is greatly increased
and the reads are considerably longer.50 This lowers costs and
aids read assembly. Currently available TGS technologies havelimitations: error rates are high at 5% and the output data are
formatted differently from those yielded by Sanger et al. and
NGS.44 These issues are being addressed but, for the time
being, second generation machines are the platforms of
choice. Table II shows a comparison of different sequencing
technologies.
Analysis
The first complete S. aureus genome was published in
2001.11 As recently as 2008 only 12 complete genomic
sequences of S. aureus were available in the public domain.51
At the time of writing (July 2012) there are 178 fully anno-
tated S. aureus genomes publically available in the National
Centre for Biotechnology Information (NCBI) Reference
Sequences (RefSeq) database.52 The first few genomes of
S. aureus to be sequenced were fully annotated with the
position of each gene and probable function stated when
known. The wealth of information contained in these annota-
tions makes these genomes desirable choices for use as refer-
ences. With higher sequencing throughput now achievable,
much larger numbers of genomes can be sequenced and the
emphasis has shifted from annotation to data analysis. The
depth of analysis required depends on the question being
asked. For example, full annotations as described above are
not necessary for determining the relatedness of isolates in
transmission and outbreak investigations. In such situations
comparisons are required between strains in terms of single
nucleotide variants (SNVs) and insertion or deletion events.
Molecular clock calibration
As a bacterial population evolves and diversifies from
a common ancestor its constituent members accumulate
differences in their genome sequences. By comparing
sequence data it is possible to infer phylogenetic relationships.
A key requirement when interpreting such data is to be able to
calibrate the molecular clock, i.e. estimate the rate at which
mutations accumulate during the evolution of a genome. With
knowledge of the molecular clock, it is possible directly to
convert a number of differences between two genomes into
the length of evolutionary time that has elapsed since they last
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some uncertainty. The molecular clock may not tick at
a constant speed in different settings (environment,
commensal and in blood for example), in different hosts or
even across lineages. Harris et al. used a linear regression
between isolation dates and root-to-tip distances in a phylo-
genetic reconstruction to estimate an average rate of
3.3  106 mutations per site per year in S. aureus.53 Over the
whole genome, this represents an average of 9.2 mutations per
genome per year. A similar rate was estimated by Young et al.
for carriage isolates sampled serially from the same patients
using the Bayesian phylogenetic method BEAST.4,54 This rate is
high enough to envision the application of WGS to the investi-
gation of patient-to-patient transmission.Hurdles and expectations
Besides the technical challenge of specimen preparation
and sequencing, even greater hurdles to putting WGS into
routine practice lie in how to perform bioinformatic analysis
and optimize information technology infrastructure for data
storage and exchange. The implementation of WGS to near
real-time infection control practice would require expertise in
technical issues of sequencing plus collaboration with
specialist teams of bioinformaticians and analysts. However, it
seems reasonable to predict that bench-top sequencers will
become increasingly accessible and user-friendly. A secure
central database could be developed for exchange of data that
would allow interpretation of sequence data within a given
epidemiological context. Being able to cope with huge volumes
of data will be a challenge. Furthermore, with the rapid
evolution of technologies, flexibility for forward and backward
integration will be required; to be compatible with previous
typing techniques and to support output data from newly
evolving platforms.Translating WGS of S. aureus from research into
practice
Harris et al. used WGS to assess the diversity of an MRSA
lineage across time, across continents and within the individual
healthcare setting.53 They provided estimates of mutation
rate, demonstrated geographical clustering of isolates and
showed how the difference in number of mutations can be used
to distinguish transmission from endemic infection. Using this
method, they found evidence suggestive of hospital-based
transmission of MRSA between patients staying in the same
hospital in Thailand. Another research group used WGS to
demonstrate the emergence in a localized hospital setting of
a new MRSA clone within ST36 that was indistinguishable from
other members of the same sequence type by conventional
methods (R. Miller, J. Price, E. Batty et al., unpublished data).
WGS appears to be uniquely well suited to detect new
pathogen variants as they emerge, track their spread and
direct effort to formulate infection control strategies. WGS is
increasing our understanding of the micro-evolution of
S. aureus during long-term carriage and its relationship with
disease states. Young et al. used WGS to investigate serial
isolates of S. aureus during long-term carriage and later during
an episode of invasive disease.4 This showed a mutation rate
(roughly one mutation per genome every seven weeks) duringlong-term carriage similar to that estimated by Harris et al. for
the mutation rates within a single lineage, ST239. However,
blood culture isolates differed from the ancestral colonizing
strain by eight mutations. As a consequence, the invasive
strain’s genome incorporated stop codons that encoded
a truncated regulatory protein, thereby providing potential
clues about the nature of the changes associated with
pathogenesis. McAdam et al. applied WGS to 87 isolates to
show how EMRSA-16 emerged 35 years ago, and spread in the
UK by transmission from hospitals in large cities to regional
locations.55
Rapid desktop sequencers are becoming affordable for use
in routine diagnostic laboratories. Eyre et al. showed that
using desktop machines it was possible to ‘rule in’ isolates
from a suspected outbreak as being truly related at the core
genome level despite conflicting evidence of differing anti-
biotic resistance profiles within a five-day turnaround
period.56 This demonstrated the unreliability of typing tools
based on phenotypic characteristics encoded by genes
present in mobile genetic elements. Conversely, this same
study demonstrated that WGS could be used to ‘rule out’
cases during an outbreak investigation even when all of the
isolates examined were from the same geographical area and
belonged to the same unusual spa type. Ko¨ser et al. used
desktop sequencing to characterize a suspected outbreak on
a neonatal intensive care unit of an MRSA strain with an
unusual antibiotic susceptibility pattern.57 Phylogenetic
reconstructions of seven MRSA isolates highlighted tight
genetic clustering of suspected strains and confirmed the
outbreak.Experience with other pathogens
Whole genome sequencing has also been applied to other
major pathogens in order to improve our understanding of
their epidemiology. He et al. used WGS to demonstrate that
the strains of Clostridium difficile associated with disease
emerged from multiple lineages.58 This contradicted the
received wisdom that bacterial pathogens arise from a single
lineage as a result of gaining genetic properties through gene
transfer or mutation. Didelot et al. used WGS to investigate
cases of C. difficile infection that appeared to be linked
according to conventional typing results (X. Didelot, D. Eyre,
M. Cule et al., unpublished data). The resolution provided by
WGS made it possible to ‘rule out’ transmission for the
majority of cases, thereby challenging the assumption that
C. difficile infection is usually acquired as a result of direct
transmission from symptomatic patients. WGS has already
been applied during the investigation of some high-profile
outbreaks. The Asian origins of the Haitian outbreak of
cholera that killed several thousand people in 2010e2011
were determined through WGS of the outbreak strain of
Vibrio cholera.59 In 2003 WGS was used to characterize the
severe acute respiratory syndrome virus, showing it to be
a previously unrecognized coronavirus.60 In 2011 sequencing
technology was used to characterize a Shiga-toxin producing
Escherichia coli O104:H4 strain that affected nearly 4000
people and caused 47 deaths in Europe and North America.
Sequencing rapidly confirmed clonal expansion from
a common ancestor and allowed identification of virulence
factors.61 Gardy et al. used WGS to evaluate a Canadian
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guishable by conventional genetic fingerprinting methods
(MIRU-VNTR), and epidemiological information suggested
a probable point source. WGS of isolates revealed that two
distinct lineages were circulating simultaneously. Evolu-
tionary analysis using historical isolates from the region
showed that both lineages were present long before the dual
outbreak was recognized. WGS was able to ‘rule in’ four
historical tuberculosis cases that had not previously been
recognized as part of the outbreak. Hence, WGS provides
a tool for optimizing contact tracing resources.Potential for WGS and possible consequences
Whole genome sequencing has the potential to improve our
understanding of phylogeny, transmission and pathogenesis
and to provide information that will enhance surveillance,
guide outbreak investigation and improve disease manage-
ment. When put into practice WGS could revolutionize the
principles of reference microbiology and taxonomy.Transmission and outbreaks
In the UK in recent decades, strategies to prevent noso-
comial acquisition of S. aureus have been focused on the
prevention and control of MRSA infection. This focus is partly
explained by the ease in being able to differentiate MRSA
from sensitive strains and the recognition of the burden of
disease caused by MRSA. However, the lack of resolution
offered by conventional typing methods has hampered our
ability to form a sound evidence base from which we might
optimize our practice. WGS will allow us to ‘rule in’ and ‘rule
out’ links between otherwise indistinguishable isolates
during the course of an investigation and give us the tool
that we need to evaluate infection control practice.Epidemiological surveillance
WGS offers the prospect of a typing system that could be
applied globally to S. aureus surveillance. Genome sequencing
of isolates in local laboratories would permit real-time gener-
ation of locally and nationally relevant epidemiological data,
allowing strains to be tracked, their relative importance eval-
uated and control efforts to be meaningfully targeted.
Furthermore, the higher level of discrimination will permit the
detection and monitoring of newly emerging strains. Linked
with clinical surveillance data, this could provide an early
warning system.Phylogeny
As the WGS knowledge base grows, a much better under-
standing of staphylococcal population structures will be
developed. Genomic comparisons over time and space of
isolates will provide clearer insights into the evolutionary
history of S. aureus. WGS will help us to understand the bio-
logical significance of genetic variation in bacteria. It will
enhance our understanding of the effects of selective pressures
(e.g. antibiotic exposure) on bacterial populations and the
biology of pathogenesis.Phenotypic predictions
Since a whole genome sequence contains the sum of the
genetic information that determines an organism’s phenotype,
the current plethora of phenotypic tests could in principle be
substituted by WGS. The relationship between genotype and
differences in phenotype in clinically relevant strains can be
investigated. For example, desktop sequencing has been shown
to allow rapid identification of mutations associated with
unusual antibiotic susceptibility patterns, variations in strain
growth rates, and the development of small colony variants.57
As long as the association between genotype and phenotype
are well understood, in silico interrogation of a WGS could be
used to predict antibiotic resistance and virulence and effec-
tively guide management earlier. For example using a ‘basic
local alignment search tool’ (BLAST).63 An automated frame-
work exists (BIGSdb) for simultaneously querying several genes
from several genomes.64 This approach also provides a bridge
between WGS and previous methods based on sequencing such
as spa-typing or MLST since the loci targeted by these methods
can be extracted from the whole genomes. PFGE and MLVA
types should also be predicted directly fromWGS data. This will
ensure that the wealth of information that has been accumu-
lated using these previous typing methods does not go to
waste. Genome-wide association studies to uncover the
genetic basis of severe disease phenotypes could be under-
taken.65 In addition to known associations there is the potential
to identify previously unknown virulence genes associated with
clinical phenotypes. This is highlighted by the discovery of
more than 70 novel candidate virulence factors that were
identified when the first two S. aureus genomes were
sequenced.11 A recent comparison of three S. aureus whole
genomes isolated sequentially over a period of 26 months from
the same cystic fibrosis patient revealed several genes under
diversifying selection which could indicate that they play an
essential role for chronic infection.66 As sequencing of the
human genome becomes more routine it will be possible to
investigate in great detail the genetic basis for the interplay
between host and commensal or pathogen. It might for
example become possible to determine the reasons why some
people become persistent carriers while others do not. It may
become possible to predict susceptibility to invasive staphy-
lococcal infection and to target preventive measures
accordingly.
With the continuing fall in sequencing costs it is conceivable
that sequence-based methodologies might replace traditional
methods as frontline diagnostic tests. There would then be
a need to develop systems to check the reliability of WGS
outputs as predictors of phenotypic characteristics such as
antibiotic susceptibility. Such needs could define one of the
core functions of future reference laboratories.
Consequences for identification and nomenclature
Bacteria are identified through a process of comparison of
the features exhibited by the test isolate with those of the type
culture that has been designated and archived by the author of
the species. For convenience, when identifying a bacterium,
most microbiologists make do with reference to a published
account of the distinguishing features of a species rather than
to make a direct comparison with the actual type culture.
Widespread access to WGS makes it possible to extend the
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of a universally accessible ‘type sequence’. Identification will
become more reliable. It will be possible to define the limits of
genetic variation within a species, to define lineages more
precisely and to define new species with greater accuracy.
Conclusion
Whole genome sequencing has the potential to replace
a multitude of diagnostic and reference tests. For the
purposes of outbreak investigation and surveillance, WGS of
S. aureus yields results of greater utility than can be achieved
using conventional techniques. Furthermore, WGS data may
be used to predict phenotypic characteristics. WGS is also
applicable to studies that seek to address questions about the
biology of S. aureus and the relationship between pathogen
and host.
At the time of writing, WGS of S. aureus is technically
difficult and is the preserve of the research community.
Compared with many conventional approaches, WGS is still
relatively expensive. The bioinformatic processing and inter-
pretation of sequence data are particularly challenging. Also
the issues around storing and transmitting cannot be
underestimated.
Despite these challenges, the steady decline in sequencing
costs and the increasing ease of use of sequencing machines
and their data outputs suggest that WGS will eventually replace
a whole suite of current test strategies. It seems clear that WGS
will revolutionize our understanding of S. aureus and our ability
to manage it as a pathogen.
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